Investor mix
6 investors on record; lead investors include CDIB Capital Group.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 83% |
| Private equity | 1 | 17% |
Developer of injectables and NCEs for cancer and chronic diseases
6 investors on record; lead investors include CDIB Capital Group.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 83% |
| Private equity | 1 | 17% |